Alignment Healthcare, Inc. (ALHC)

盈利方式

Almost all revenue is a capitated, fixed monthly payment per enrolled member (PMPM) received from CMS: earned premiums were $3,911.7 million in fiscal 2025, 99.1% of total revenue, with the remaining 0.9% ($37.0 million) coming from interest on cash and investments and services sold to third-party providers. The PMPM amount varies with the county where the member lives, the documented health risk of the population (the CMS risk-adjustment model) and the plan's CMS Star Ratings; Part D drug coverage is paid separately by CMS. Each year plans submit bids against a county benchmark of what Traditional Medicare would spend, and plans that come in below the benchmark keep part of the saving as a rebate, which they must spend on richer benefits. Out of that fixed premium Alignment pays every covered medical cost of its members: medical expenses absorbed 87.6% of revenue in 2025 and SG&A a further 11.2%, which is why the whole model turns on keeping utilisation below what the premium assumed. Members enrol for one year at a time and renew annually.

Alignment describes its 'virtuous cycle' — using AVA and in-house clinical teams to cut medical costs, then reinvesting the savings in richer benefits to win members — as 'a distinct and sustainable competitive advantage'. The same filing, however, undercuts the durability of that claim: in its competition section the company writes that 'barriers to entry in our markets are not substantial, so the addition of new competitors can occur relatively easily, and customers enjoy significant flexibility in moving between competitors', that many competitors have a larger membership base and greater financial resources, and that contracts are re-set every year through the CMS bidding process. A senior can switch plan at the next annual enrolment at no cost, so there are no switching costs to speak of; the payment rates, the risk-adjustment model and the Star Ratings that drive economics are all set by a regulator, not by the company. High Star Ratings and the clinical model are real operating strengths, but on the company's own account they must be re-earned every single year, which is not what a durable moat looks like.

Demand here is demographic and regulatory, not economic. Members are seniors who become eligible for Medicare at 65 and enrol for one year at a time, renewing during the annual enrolment period; the company grew health plan membership from about 13,000 at inception to 236,300 at the end of 2025 and to roughly 275,300 as of 1 January 2026, a path that owes nothing to the business cycle. A recession does not stop people turning 65, and the premium is paid by CMS, so the revenue line is insulated from consumer spending. What does move with the cycle is the other side of the equation: medical utilisation, which drives the cost of serving those members, plus the political and budgetary decisions that set CMS benchmark rates each year. The company itself notes in its risk factors that healthcare utilisation has historically trended upward regardless of minor fluctuations in the U.S. economy, but that as consumers take on more spending responsibility they may treat care — especially elective procedures — as more discretionary, which could make utilisation more cyclical and cause short-term volatility in operating results.

主要风险

• A history of net losses since inception — The company states it has incurred net losses every year since inception — $1.0 million in 2025 and $128.1 million in 2024 — with an accumulated deficit of $1,009.0 million at 31 December 2025. It expects aggregate costs to increase substantially as it invests in membership growth, provider networks, geographic expansion, marketing and technology, and warns it may not raise revenue enough to offset them, or predict and manage members' medical costs successfully.
• Everything depends on CMS, and CMS contracts renew every year — The filing states that the Medicare Advantage programme accounted for substantially all of total revenue in 2025. CMS contracts are subject to annual renewal and CMS must approve each year's bids; losing a contract, or a material change to its terms, would hit results directly. Congress or CMS may at any time change premium amounts, mandated benefits, eligibility criteria or payment timing, and CMS sets county benchmark rates annually that may fall or fail to keep pace with medical costs. The company also lists suspension from the programme, changes to Part D risk sharing, and government audits and investigations among the risks of being a government contractor.
• Star Ratings can fall, and the rules keep changing — The company warns it may not maintain or improve its Star Ratings, with a direct and substantial impact on revenue, since higher-rated plans receive extra payments. It notes it depends on third-party providers and vendors it cannot fully control for the outcomes that feed the ratings, that its higher concentration of minority members and members in socioeconomically disadvantaged neighbourhoods makes high ratings harder to achieve, and that CMS changes the methodology annually — it cites the 2024 outlier-deletion change that raised cut points, and further proposed changes for the 2027 ratings.
• Risk-adjustment coding and RADV audits — Revenue depends on diagnosis data submitted to CMS, largely coded by providers, and the company warns its records may contain inaccurate or unsupportable risk-adjustment information, which could misstate revenue and expose it to penalties. It describes CMS and HHS-OIG Risk-Adjustment Data Validation (RADV) audits and the January 2023 final rule under which CMS would extrapolate audit results across a whole contract from payment year 2018 onward and would apply no fee-for-service adjuster — changes the company says would be expected to have a material impact on Medicare Advantage organisations including itself. CMS began the 2018 payment-year audits in November 2024 and expected to issue findings in mid-2026.
• Medical cost estimates can be wrong — The company lists inaccurate estimates of incurred but not reported medical expense as a risk that could adversely affect results, alongside the risk of not designing and pricing products properly and competitively, not lowering costs or documenting members' risk profiles adequately, or setting inadequate benefits-expense estimates — any of which could materially hurt profitability.
• Geographic concentration: 84% of members are in California — The company discloses that approximately 84% of its members were concentrated in California as of 31 December 2025, with the rest in North Carolina, Nevada, Arizona and Texas, so its exposure is not mitigated by geographic diversification. Adverse changes in benefit costs, reimbursement rates or competition in those states, or events such as infectious-disease outbreaks, a major earthquake, wildfire or hurricane, could have a disproportionate effect on results.
• Dependence on provider networks and on key IPA contracts — The company warns that failing to develop and maintain satisfactory relationships with care providers could adversely affect the business, and specifically that the loss or renegotiation of certain key contracts with large independent physician associations (IPAs), hospitals or other provider networks serving its membership could negatively impact results. It also flags competition for physicians and nurses and shortages of qualified personnel as a source of higher labour costs.
• Cybersecurity, data and the use of AI in AVA — The company lists cybersecurity breaches and loss of data as risks that could compromise sensitive business or member information and expose it to liability, and separately warns that its use of machine learning and artificial intelligence, including within the AVA platform, may introduce operational, regulatory and legal risks. It also depends on the uninterrupted operation and data integrity of its information technology platform and on its ability to license and integrate third-party data.

In economic terms Alignment has one customer, the U.S. federal government. The filing states that the Medicare Advantage programme accounted for substantially all of total revenue for the year ended 31 December 2025, and that the company depends on reimbursements from CMS together with premium payments by individuals; earned premiums alone were 99.1% of total revenue in 2025. The filing does not, however, state a single figure for the share of revenue attributable to CMS as a payer, so no precise percentage can be given. The individual member base is fragmented — 236,300 members at the end of 2025 — but each of them is a source of cost, not of revenue: the money comes from one payer whose rates, contracts and audit rules are all re-set annually.